Deakin University
Browse

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Version 2 2024-06-04, 04:31
Version 1 2017-09-01, 00:00
journal contribution
posted on 2024-06-04, 04:31 authored by GM Duchesne, HH Woo, M King, Steve BoweSteve Bowe, MR Stockler, A Ames, C D'Este, M Frydenberg, A Loblaw, S Malone, J Millar, KH Tai, S Turner
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

History

Related Materials

Location

England

Language

English

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2017, Elsevier

Journal

The Lancet Oncology

Volume

18

Pagination

1192-1201

ISSN

1470-2045

eISSN

1474-5488

Issue

9

Publisher

ELSEVIER SCIENCE INC